Accelerate the drug development process by identifying immunogenic peptides, such as neo-antigens and viral antigens, at an early stage. This enables the selection of compounds that can trigger desired immune responses. Having an understanding of a biotherapeutic's immunogenic profile facilitates the establishment of a robust R&D strategy, ensuring a seamless transition to the next stages of the drug development process.
Utilize immunogenic profiling to develop sturdy protocols and mitigate the risk of adverse events during the clinical phase of your drug development.
By accurately identifying antigen presentation hotspots on a molecule, you can gain a comprehensive understanding of the compound's immunogenic potential. This will aid in determining the necessary modulations to optimize drug design.
Institute of Tropical Medicine Antwerp
An advanced drug development process.
The benefits of immunogenic profiling.
The identification of a compound's immunogenic areas shows beneficial effects at different stages of the drug development process.